Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2021-06-09
Target enrollment:
Participant gender:
Summary
This research study is studying a combination of targeted therapies as a possible treatment
for Advanced Solid Tumors.
The study interventions involved in this study are:
- LY2606368
- Olaparib